Carbios SAS/€ALCRB
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Carbios SAS
Carbios SAS is a French biotechnology company specializing in developing enzyme-based processes for the recycling and biodegradation of plastics and textiles. Founded in 2011 and headquartered in Clermont-Ferrand, France, Carbios focuses on enzymatic depolymerization technologies to break down PET plastics into their original monomers, facilitating the production of new, virgin-quality plastics. The company operates a demonstration plant in Clermont-Ferrand and is constructing the world's first industrial-scale PET biorecycling facility in Longlaville, France, with an expected processing capacity of 50,000 tons per year. Carbios collaborates with major global brands, including Nestlé Waters, PepsiCo, and L'Oréal, to enhance the recyclability and circularity of their products.
- Ticker
- €ALCRB
- Sector
- Materials
- Primary listing
- PAR
- Employees
- 91
- Headquarters
- Clermont-Ferrand, France
- Website
- www.carbios.com
Carbios SAS Metrics
BasicAdvanced
€83M
-
-
1.52
-
Price and volume
Market cap
€83M
Beta
1.52
52-week high
€15.79
52-week low
€5.02
Average daily volume
15K
Financial strength
Current ratio
21.781
Quick ratio
21.655
Long term debt to equity
0.164
Total debt to equity
0.164
Interest coverage (TTM)
-13.41%
Profitability
EBITDA (TTM)
-3.306
Gross margin (TTM)
-59.23%
Net profit margin (TTM)
-609.74%
Operating margin (TTM)
-404.47%
Effective tax rate (TTM)
4.84%
Revenue per employee (TTM)
€60,000
Management effectiveness
Return on assets (TTM)
-5.68%
Return on equity (TTM)
-17.60%
Valuation
Growth
Revenue change (TTM)
796.05%
3-year revenue growth (CAGR)
300.80%
10-year revenue growth (CAGR)
18.68%
Carbios SAS Financial Performance
Revenues and expenses
Carbios SAS Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.